Abnormal whole-body technetium-99m MDP scintigraphy indicating cortical hyperostosis following long-term administration of prostataglandin E-1 in an infant with cyanotic congenital heart disease.
D000527:Alprostadil / Q000009:adverse effects* / Q000627:therapeutic use; D001842:Bone and Bones / Q000000981:diagnostic imaging*; D004334:Drug Administration Schedule; D004374:Ductus Arteriosus, Patent / Q000188:drug therapy; D006801:Humans; D006958:Hyperostosis, Cortical, Congenital / Q000139:chemically induced / Q000000981:diagnostic imaging*; D007223:Infant; D008297:Male; D011877:Radionuclide Imaging; D013669:Technetium Tc 99m Medronate; D013997:Time Factors
D000527:Alprostadil; D013669:Technetium Tc 99m Medronate